Respiratory syncytial virus diagnostic Market Segmentation, Analysis and Forecast 2020

1. Respiratory Syncytial Virus Diagnostic Market 2020

2. SYNOPSIS The report provides market analysis, information and insights into “Respiratory Syncytial Virus Diagnostic Market 2020” About Respiratory Syncytial Virus Diagnostic Respiratory syncytial virus (RSV) is a virus which causes respiratory infections such as bronchiolitis and pneumonia. Globally, the cases of RSV infections are on the rise which is fueling the demand for rapid diagnostic techniques. According to the CDC, each year, on an average, RSV leads to the hospitalization of around 1,32,000- 172,000 children below the age of five and the death of around 14,000 adults above the age of 65, in the United States alone. This rising incidence of RSV infections is the major driving force for this market. View more details @ http://www.bigmarketresearch.com/respiratory-syncytial-virus-RSV-diagnostic-market

3. KEY MARKET BENEFITS: • In depth analysis of current technologies used in the RSV diagnostic enables strategic decision making by stakeholders • Identification of drivers, restraints and opportunities in the market • Market segmentation based on technology, end users and geography helps in exploring new business opportunities. • Analysis of the key players in the market and the technologies developed by them would help in understanding strategies implemented by the competitors

4. KEY PLAYERS Some of the key players in this market are Abott Laboratories, Becton Dickinson and Company, bioMerieux, Bio-Rad Laboratories, Beckman Coulter Thermo Fisher Scientific and EMD Millipore. In 2001, Abott and IntelligentMDx (IMDX) entered into an agreement in which IMDx would develop and design real time PCR assays for the Abott m2000 instrument system. The IMDx Flu A/B and RSV test is one such test developed by IntelligentMDx (IMDX) of Cambridge, for Abbott's m2000 molecular diagnostics system. The test is a qualitative Reverse Transcription test for rapid detection of different strains of RSV as well Influenza A, and Influenza B. The test could analyze 94 samples per run and it is fully automated with minimal turnaround time.

5. SUMMARY The report gives an in depth analysis of the RSV diagnostic market. The buyers’ power in this market is high, as there are many suppliers providing diagnostic kits for RSV. The threat of new entrants in the market is low as there are highly differentiated diagnostic kits manufactured by established companies and initial capital investment required is high. The threat of substitutes is low due lack of alternative diagnostic technology for detection of RSV. Enquire About Report @ http://www.bigmarketresearch.com/report-enquiry/22814

6. CONTACT US Big Market Research Deep Joshi 5933 NE Win Sivers Drive, #205, Portland, OR 97220 United States Direct : + 1-503-894-6022 Toll Free : + 1-800-910-6452 Fax : +1 (855) 550-5975 Email: help@bigmarketresearch.com Web: http://www.bigmarketresearch.com